OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential Clinical and Serological Predictors of Chronic Spontaneous Urticaria Relapse in Patients Under Omalizumab Treatment
Teresa Grieco, Laura Dies, Alvise Sernicola, et al.
Immunotherapy (2020) Vol. 12, Iss. 16, pp. 1173-1181
Open Access | Times Cited: 21
Teresa Grieco, Laura Dies, Alvise Sernicola, et al.
Immunotherapy (2020) Vol. 12, Iss. 16, pp. 1173-1181
Open Access | Times Cited: 21
Showing 21 citing articles:
Total IgE as a Marker for Chronic Spontaneous Urticaria
Sabine Altrichter, Jie Shen Fok, Qingqing Jiao, et al.
Allergy Asthma and Immunology Research (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 89
Sabine Altrichter, Jie Shen Fok, Qingqing Jiao, et al.
Allergy Asthma and Immunology Research (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 89
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
Kai‐Wen Chuang, Che-Yuan Hsu, Shiu‐Wen Huang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2382-2389.e3
Closed Access | Times Cited: 25
Kai‐Wen Chuang, Che-Yuan Hsu, Shiu‐Wen Huang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2382-2389.e3
Closed Access | Times Cited: 25
The Role of Oxidative Stress in Atopic Dermatitis and Chronic Urticaria
Sabina Galiniak, Mateusz Mołoń, Marek Biesiadecki, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 27
Sabina Galiniak, Mateusz Mołoń, Marek Biesiadecki, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 27
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know
Dorothea Terhorst‐Molawi, Lena Fox, Frank Siebenhaar, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 3, pp. 397-404
Open Access | Times Cited: 15
Dorothea Terhorst‐Molawi, Lena Fox, Frank Siebenhaar, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 3, pp. 397-404
Open Access | Times Cited: 15
The Role of Coagulation/Fibrinolysis Biomarkers in Pathophysiology, Disease Severity, and Treatment Response in Patients with Urticaria: A Scoping Review
Haiyan Qin, Xianjun Xiao, Ping Xue, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Haiyan Qin, Xianjun Xiao, Ping Xue, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study
Teresa Grieco, Luca Ambrosio, Federica Trovato, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1822-1822
Open Access | Times Cited: 18
Teresa Grieco, Luca Ambrosio, Federica Trovato, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1822-1822
Open Access | Times Cited: 18
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 5, pp. 592-600
Open Access | Times Cited: 13
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 5, pp. 592-600
Open Access | Times Cited: 13
Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review
Benjamin Greiner, Savannah Nicks, Michael Adame, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 3, pp. 381-389
Closed Access | Times Cited: 12
Benjamin Greiner, Savannah Nicks, Michael Adame, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 3, pp. 381-389
Closed Access | Times Cited: 12
Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
Maria Maddalena Sirufo, Enrica Maria Bassino, Francesca De Pietro, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 12
Maria Maddalena Sirufo, Enrica Maria Bassino, Francesca De Pietro, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35
Open Access | Times Cited: 12
Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
Michihiro Hide, Atsushi Fukunaga, Takayuki Suzuki, et al.
Allergology International (2022) Vol. 72, Iss. 2, pp. 286-296
Open Access | Times Cited: 7
Michihiro Hide, Atsushi Fukunaga, Takayuki Suzuki, et al.
Allergology International (2022) Vol. 72, Iss. 2, pp. 286-296
Open Access | Times Cited: 7
Potential Immunological Biomarkers in Chronic Spontaneous Urticaria Patients Receiving Omalizumab Treatment
Rabia Öztaş Kara, Kaan Furkan Hamarat, Gamze Güney Eskiler, et al.
Research Square (Research Square) (2024)
Closed Access
Rabia Öztaş Kara, Kaan Furkan Hamarat, Gamze Güney Eskiler, et al.
Research Square (Research Square) (2024)
Closed Access
Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria
Olga Branicka, Barbara Rymarczyk, Radosław Gawlik, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4287-4287
Open Access
Olga Branicka, Barbara Rymarczyk, Radosław Gawlik, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4287-4287
Open Access
Is there a difference between women and men in chronic spontaneous urticaria? A systematic review on gender and sex differences in CSU patients
Sarah Preis, Carla Claussen, Stefanie Ziehfreund, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 11, pp. 100974-100974
Closed Access
Sarah Preis, Carla Claussen, Stefanie Ziehfreund, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 11, pp. 100974-100974
Closed Access
Exploring Long Non-Coding RNAs Associated with IP3/DAG Signaling Pathway as Potential Biomarkers Involved in Mast Cell Degranulation in Chronic Spontaneous Urticaria with 2-Year Follow-Up
Yudan Liang, Qinghuo Kong, Huiwen Luo, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 267-283
Open Access | Times Cited: 2
Yudan Liang, Qinghuo Kong, Huiwen Luo, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 267-283
Open Access | Times Cited: 2
Skin Dialogues in Atopic Dermatitis
Elena Porumb‐Andrese, Claudia Florida Costea, Andrei Ionuţ Cucu, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1889-1889
Open Access | Times Cited: 2
Elena Porumb‐Andrese, Claudia Florida Costea, Andrei Ionuţ Cucu, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1889-1889
Open Access | Times Cited: 2
Urticaria
Roberta Fachini Jardim Criado, Paulo Ricardo Criado
Springer eBooks (2023), pp. 1673-1707
Closed Access
Roberta Fachini Jardim Criado, Paulo Ricardo Criado
Springer eBooks (2023), pp. 1673-1707
Closed Access
¿Qué hay de nuevo sobre los biomarcadores en urticaria crónica espontánea? Revisión de la literatura de los últimos años. Parte 1: etiopatogenia, diagnóstico, pronóstico y severidad
Carolina Gómez Núñez, David Godoy Sánchez, Fernando Valenzuela
Piel (2023) Vol. 38, Iss. 6, pp. 394-401
Closed Access
Carolina Gómez Núñez, David Godoy Sánchez, Fernando Valenzuela
Piel (2023) Vol. 38, Iss. 6, pp. 394-401
Closed Access
¿Qué hay de nuevo sobre los biomarcadores en urticaria crónica espontánea? Revisión de la literatura de los últimos años. Parte 2: biomarcadores actuales y futuros
Carolina Gómez Núñez, David Godoy Sánchez, Fernando Valenzuela
Piel (2023) Vol. 38, Iss. 7, pp. 450-457
Closed Access
Carolina Gómez Núñez, David Godoy Sánchez, Fernando Valenzuela
Piel (2023) Vol. 38, Iss. 7, pp. 450-457
Closed Access
Is Omalizumab Treatment Used During the COVID-19 Pandemic Effective on the Frequency and Severity of COVID-19?
Rabia Öztaş Kara, Bahar Sevimli Dikicier, Ahmet Can YAĞMUR, et al.
Online Türk Sağlık Bilimleri Dergisi (2023) Vol. 8, Iss. 3, pp. 369-374
Open Access
Rabia Öztaş Kara, Bahar Sevimli Dikicier, Ahmet Can YAĞMUR, et al.
Online Türk Sağlık Bilimleri Dergisi (2023) Vol. 8, Iss. 3, pp. 369-374
Open Access
Omalizumab for the management of refractory chronic spontaneous urticaria
PC Kathuria, Manisha Rai
Indian Journal of Allergy Asthma and Immunology (2022) Vol. 36, Iss. 2, pp. 65-72
Open Access
PC Kathuria, Manisha Rai
Indian Journal of Allergy Asthma and Immunology (2022) Vol. 36, Iss. 2, pp. 65-72
Open Access
Omalizumabe versus ciclosporina‐A para o tratamento da urticária crônica espontânea: podemos definir endótipos com melhor resposta?
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
(2022) Vol. 97, Iss. 5, pp. 592-600
Open Access
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
(2022) Vol. 97, Iss. 5, pp. 592-600
Open Access
